Your session is about to expire
← Back to Search
LLS Program Services for Blood Cancer
N/A
Waitlist Available
Led By Frank Penedo, PhD
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 month, 6 month
Awards & highlights
Study Summary
This trial will study how the Leukemia & Lymphoma Society helps patients with blood cancer access care, improve quality of life, & reduce financial burden.
Who is the study for?
This trial is for blood cancer patients currently undergoing treatment who have unmet needs that the Leukemia and Lymphoma Society's (LLS) Program aims to address. Participants must speak English or Spanish, not be using LLS services already, and agree to a 6-month follow-up.Check my eligibility
What is being tested?
The study evaluates how the LLS Program affects blood cancer patients' access to care, quality of life, and financial burden. It seeks to understand if these services fill gaps in their current care regimen over a six-month period.See study design
What are the potential side effects?
Since this trial involves participation in support programs rather than medical treatments, there are no direct physical side effects associated with traditional clinical interventions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 3 month, 6 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 month, 6 month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in number of care needs as measured by the Access to Care Survey
Change in number of medication access problems as measured by the Access to Care Survey
Secondary outcome measures
Change in financial toxicity as measured by FACIT-COST
Change in general health-related quality of life (HRQL)
Change in treatment satisfaction as measured by FACIT
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: LLS Program and Usual Care GroupExperimental Treatment1 Intervention
Participants in the LLS Program and Usual Care condition will receive LLS services such as information, services, and financial aid so that patients can have better access to healthcare and better quality of life. Participants will also receive the standard care. Participants will be in this group for 6 months.
Group II: Usual Care GroupActive Control1 Intervention
Participants will receive the standard care. Participants will be in this group for 6 months.
Find a Location
Who is running the clinical trial?
University of MiamiLead Sponsor
899 Previous Clinical Trials
409,332 Total Patients Enrolled
6 Trials studying Leukemia
104 Patients Enrolled for Leukemia
The Leukemia and Lymphoma SocietyOTHER
82 Previous Clinical Trials
16,731 Total Patients Enrolled
41 Trials studying Leukemia
3,591 Patients Enrolled for Leukemia
Frank Penedo, PhDPrincipal InvestigatorUniversity of Miami
2 Previous Clinical Trials
360 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not speak English or Spanish.I need help with medical care, travel, trials, finances, or learning about my disease.I do not need help with medical care, travel, trials, finances, or education about my disease.I am currently being treated for leukemia, lymphoma, myeloma, MDS, or MPN.I speak English or Spanish.I am not willing to participate in follow-up for 6 months.I am not currently being treated for leukemia, lymphoma, myeloma, MDS, or MPN.
Research Study Groups:
This trial has the following groups:- Group 1: LLS Program and Usual Care Group
- Group 2: Usual Care Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are people able to participate in this clinical experiment at the present moment?
"As indicated on the clinicaltrials.gov website, this medical trial is not currently accepting participants. Having first been posted on May 1st 2023 and last updated February 16th 2023, it has since concluded its recruitment phase; however, 3020 other trials are still actively searching for patients."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger